Entero Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$15,794,983 over the previous period. Total operating expenses were $15,770,827.
Profit Margin
| 2014 | 0 | -2.36M | |
|---|---|---|---|
| 2015 | 0 | -5.93M | |
| 2017 | 0 | -11.09M | |
| 2020 | 0 | -32.67M | |
| 2023 | 0 | -15.79M |
ENTO Income Statement (2014 – 2023)
| 2023 | 2020 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 29.27K | 571.14K | 753.99K | 0 | 0 |
Gross profit | -29.27K | -571.14K | -753.99K | 0 | 0 |
Operating exp. | |||||
Research and development | 5.03M | 19.13M | 2.39K | 1.39K | 1.05K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 15.77M | 26.43M | 10.22K | 4.34K | 2.88K |
Operating income | -15.77M | -26.43M | -10.08K | -4.72K | -2.91K |
Other income (expenses), net | -24.15K | -6.23M | -1.01M | -1.20M | 551.16K |
Income before tax | -15.79M | -32.67M | -11.09K | -5.93K | -2.95K |
Income tax expense | 0 | 15.11M | 0 | 0 | -587 |
Net income | -15.79M | -32.67M | -11.09M | -5.93M | -2.36M |
Earnings per share | |||||
Basic EPS | -47.88 | -61.63K | -43.68K | -25.48K | -10.16K |
Diluted EPS | -47.88 | -61.63K | -43.68K | -25.48K | -10.16K |